We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+23.43%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.4B
AUM Growth
-$5.58B
Cap. Flow
-$3.87B
Cap. Flow %
-23.65%
Top 10 Hldgs %
18.07%
Holding
3,458
New
283
Increased
974
Reduced
1,077
Closed
907

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$114M
2
BMY icon
Bristol-Myers Squibb
BMY
+$109M
3
TT icon
Trane Technologies
TT
+$106M
4
MSFT icon
Microsoft
MSFT
+$104M
5
MA icon
Mastercard
MA
+$104M

Sector Composition

Rank Sector Weight
1 Technology 23.03%
2 Healthcare 13.89%
3 Financials 11.27%
4 Consumer Discretionary 8.92%
5 Industrials 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLGX
626
DELISTED
Corelogic, Inc.
CLGX
$944K 0.01%
14,047
+5,288
+60% +$235K
GL icon
627
Globe Life
GL
$13.9B
$934K 0.01%
12,594
+10,295
+448% +$781K
ATO icon
628
Atmos Energy
ATO
$29.9B
$928K 0.01%
9,331
+6,815
+271% +$687K
STE icon
629
Steris
STE
$22.7B
$914K 0.01%
5,963
+2,939
+97% +$448K
ACWI icon
630
iShares MSCI ACWI ETF
ACWI
$32.2B
$909K 0.01%
12,352
-6,760
-35% -$472K
RL icon
631
Ralph Lauren
RL
$22.1B
$904K 0.01%
12,471
+3,466
+38% +$255K
VRTX icon
632
Vertex Pharmaceuticals
VRTX
$124B
$901K 0.01%
3,109
+594
+24% +$161K
UHS icon
633
Universal Health Services
UHS
$10.1B
$880K 0.01%
9,479
-80
-0.8% -$8K
BL icon
634
BlackLine
BL
$1.92B
$879K 0.01%
10,609
+8,799
+486% +$587K
AMTD
635
DELISTED
TD Ameritrade Holding Corp
AMTD
$879K 0.01%
24,198
-49,139
-67% -$1.85M
HBAN icon
636
Huntington Bancshares
HBAN
$34.4B
$875K 0.01%
97,085
+65
+0.1% +$575
ZION icon
637
Zions Bancorporation
ZION
$10.2B
$866K 0.01%
25,487
+22,673
+806% +$718K
PSA icon
638
Public Storage
PSA
$62.3B
$856K 0.01%
4,475
-1,211
-21% -$234K
ILMN icon
639
Illumina
ILMN
$29.3B
$850K 0.01%
2,362
-272
-10% -$87.5K
QLYS icon
640
Qualys
QLYS
$4.73B
$844K 0.01%
8,114
+6,065
+296% +$635K
EOG icon
641
EOG Resources
EOG
$77.4B
$837K 0.01%
16,563
-1,055
-6% -$51.1K
FNDF icon
642
Schwab Fundamental International Large Company Index ETF
FNDF
$24.4B
$835K 0.01%
+35,200
New +$795K
VYMI icon
643
Vanguard International High Dividend Yield ETF
VYMI
$20.3B
$834K 0.01%
+16,300
New +$796K
CDK
644
DELISTED
CDK Global, Inc.
CDK
$832K 0.01%
20,107
-1,233
-6% -$47.5K
KBR icon
645
KBR
KBR
$4.57B
$830K 0.01%
36,861
-118,394
-76% -$2.57M
HIG icon
646
Hartford Financial Services
HIG
$39.7B
$823K 0.01%
21,401
-21,820
-50% -$832K
FTS icon
647
Fortis
FTS
$29.5B
$822K 0.01%
21,594
-8,701
-29% -$332K
TDS icon
648
Telephone and Data Systems
TDS
$3.84B
$820K 0.01%
41,291
-18,621
-31% -$356K
MRO
649
DELISTED
Marathon Oil Corporation
MRO
$818K 0.01%
134,038
+109,768
+452% +$607K
PAA icon
650
Plains All American Pipeline
PAA
$17.5B
$813K 0.01%
92,112
-137,632
-60% -$1.17M

Similar funds

Glenmede Trust's Q2 2020 Portfolio in Review

As of Q2 2020, Glenmede Trust held 3,458 positions worth $16.4B, down 25% from $21.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Glenmede Trust withdrew a net $3.87B in Q2 2020, closing 907 positions and reducing 1,077 holdings. Its most notable exit was Raytheon Company, an estimated $66.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Carrier Global worth $21.3M.

  • Glenmede Trust's largest Q2 2020 buy was Carrier Global: 960,042 shares worth $21.3M.
  • Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $97.1M increase.
  • Glenmede Trust's biggest Q2 2020 reduction was Accenture, cutting an estimated $114M.
  • Glenmede Trust fully exited Raytheon Company in Q2 2020, selling an estimated $66.5M.
  • Glenmede Trust's ten largest holdings make up 18% of its $16.4B portfolio in Q2 2020.
  • Glenmede Trust opened 283 new positions and closed 907 in Q2 2020.
  • Glenmede Trust's portfolio value fell 25% quarter-over-quarter to $16.4B.

Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.